Our findings suggest that the measurement of AFP is not sufficient to detect HCC in patients with an ALT level > 2 ULN and dynamic observation of the serum AFP level during antiviral treatment is essential to avoid misleading results of AFP tests for diagnosing HCC. The gene discussed is GPT; the disease is hepatocellular carcinoma.